Nachrichten zur AstraZeneca PLC Aktie

LGND: XOMA Acquisition Closed

By John Vandermosten, CFANASDAQ: LGNDREAD THE FULL LGND RESEARCH NOTELigand Pharmaceuticals, Inc. (NASDAQ: LGND) reported second quarter 2026 results boasting…

ANALYSE-FLASH: Jefferies belässt Astrazeneca auf 'Buy' - Ziel 17500 Pence

NEW YORK (dpa-AFX Broker) - Das Analysehaus Jefferies hat die Einstufung für Astrazeneca auf "Buy"…

AstraZeneca-BMY megadeal talk sparks huge market rift

Two of the worlds biggest drugmakers moved in opposite directions on Monday, and the split says a lot about how…

Brokers split on AstraZeneca merger talk as shares recover some ground

Citi has told clients that a large chunk of deal risk is already in AstraZeneca PLCs (LSE:AZN, NASDAQ:AZN) share price after…

AstraZeneca Investors See Little Logic in Bristol Tie-Up

AstraZeneca Plc investors had a clear message for the UK drugmaker on Monday: they don’t like the idea of a $400…

Bristol-Myers Squibb and AstraZeneca said to discuss megamerger

Bristol-Myers Squibb and AstraZeneca said to discuss megamerger - can it happen?…

Analysts baffled by AstraZenecas interest in Bristol Myers Squibb

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) shares fell 6% to 11,872p on Monday, the steepest decline in the FTSE 100, as analysts struggled…

Analysts baffled by AstraZenecas interest in Bristol Myers Squibb

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) shares fell 6% to 11,872p on Monday, the steepest decline in the FTSE 100, as analysts struggled…

Stocks making the biggest moves premarket: Alibaba, AstraZeneca, eBay & more

These are the stocks posting the largest moves premarket.…

AstraZeneca slides after reports of Bristol Myers merger talks leave analysts perplexed

The companies have discussed a potential merger over several months, reports say.…

FTSE 100 held back by AstraZeneca as oil drops

The FTSE 100 started the week higher after Donald Trump said he planned to restart talks with Iran. The index rose in…

AstraZeneca shares slide 7% on talks to buy Bristol Myers Squibb

Shares in AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) fell 7% to 11,723p on Monday after news that Britains biggest drugmaker is in talks…

AstraZeneca shares slide 7% on talks to buy Bristol Myers Squibb

Shares in AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) fell 7% to 11,723p on Monday after news that Britains biggest drugmaker is in talks…

AstraZeneca shares slide 7% after reports of Bristol Myers talks

AstraZenecas shares fell sharply on Monday as analysts and investors questioned the logic of a possible tie-up with Bristol Myers…

FTSE 100 Live: London lagging as AstraZeneca plunges and commodities slip

FTSE 100 down 30 points to 10,838 Housebuilders, airlines climb as oil and bonds fall AstraZeneca drops on reports of…

FTSE 100 Live: London lagging as AstraZeneca offsets gains from oil drop

9.14am: FTSE in the red The FTSE 100 is down 2 points at 10,866 after an hour and a bit of…

FTSE 100 Live: Blue-chips to start August on front foot, AstraZeneca merger talks reported

7.47am: AstraZeneca in talks over $400 billion mega-merger AstraZeneca is in talks with Bristol Myers Squibb over a potential merger to…

FTSE 100 Live: London lagging as AstraZeneca tumbles, US tech giants rally

FTSE 100 down 14 points to 10,854 Housebuilders, airlines climb as oil and bonds fall AstraZeneca drops on reports of…

FTSE 100 Live: Blue-chips start down as AstraZeneca and oil giants sink

8.15am: FTSE flat as AstraZeneca and oil giants slump The FTSE 100 has started in an uncertain manner, currently up…

FTSE 100 Live: London lagging as AstraZeneca tumbles, Shell sells renewables arm

FTSE 100 falls 1 point to 10,867 Housebuilders, airlines climb as oil and bonds fall AstraZeneca drops on reports of Bristol-Myers…

AstraZenecas drug pipeine is splitting opinion among City analysts

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) drug pipeline is splitting opinion among City brokers, with Citibank upgrading its price target to 17,800p...…

The Zacks Analyst Blog Highlights Apple, Microsoft, Amazon, LVMH, AstraZeneca, Shell, Airbus and UBS

AAPL, MSFT and AMZN earnings join key central bank meetings as investors track AI spending, interest rates and rising geopolitical…

AstraZeneca: Q2 2026 Results Were All Right, But Farxiga Poses Risks

…

Omeros gains as AstraZenecas Ultomiris fails in rare blood disorder

…

Astrazeneca (AZN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for Astrazeneca (AZN) give a sense of how the business performed in the quarter…

FTSE 100 gains as Vodafone and AstraZeneca impress

The FTSE 100 rose on Monday as traders reacted positively to a break in fighting in the Middle East, which…

Krebsmittel treiben Wachstum von Astrazeneca an - Aktie steigt

LONDON (dpa-AFX) - Der Pharmakonzern Astrazeneca hat im zweiten Quartal zugelegt. So stieg der Umsatz…

AstraZeneca shares climbs as full-year outlook reiterated despite recent trial failure

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) shares climbed to their highest in over two weeks after the drugmaker reported better second-quarter earnings than...…

AstraZeneca shares climbs as full-year outlook reiterated despite recent trial failure

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) shares climbed to their highest in over two weeks after the drugmaker reported better second-quarter earnings than...…

AstraZeneca earnings beat forecasts despite slight revenue miss

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) reported better second-quarter earnings than expected as growth in oncology and rare diseases helped offset weaker...…

FTSE 100 Live: Stocks advance as oil price retreats, oil falls below $90

FTSE 100 up 40 points at 10,777 Oil prices drop as US and Iran pause strikes AstraZeneca and Vodafone report as…

FTSE 100 Live: Stocks advance as oil price retreats, retail downturn eases

FTSE 100 up 40 points at 10,777 Oil prices drop as US and Iran pause strikes AstraZeneca and Vodafone report as…

FTSE 100 Live: Strong start expected to busy week as AstraZeneca, Vodafone report results

FTSE 100 Live: Flying start expected to busy week The FTSE 100 is set to hit the ground running on…

FTSE 100 Live: Stocks start higher as oil price tumbles, Vodafone and AstraZeneca impress

8.15am: FTSE 100 springs higher at open, led by Vodafone The FTSE 100 has begun the week with a spring…

FTSE 100 Live: Stocks advance as oil price retreats, Chinas new chip champion IPOs

FTSE 100 up 40 points at 10,777 Oil prices drop as US and Iran pause strikes AstraZeneca and Vodafone report as…

AstraZeneca reiterates annual guidance after topping Q2 profit expectations

AstraZeneca reiterates annual guidance after topping Q2 profit expectations…

AstraZeneca magic faces rare test after trial failure, share slide

AstraZenecas long-time CEO Pascal Soriot has rarely put a foot wrong. The companys shares have more that quadrupled in price…

Jefferies says September lung data can offset AstraZeneca trial failure

Jefferies believes detailed data on AstraZeneca PLCs (LSE:AZN, NASDAQ:AZN) experimental lung drug tozorakimab could more than compensate investors for the...…

Astrazeneca (AZN) Falls More Steeply Than Broader Market: What Investors Need to Know

Astrazeneca (AZN) closed the most recent trading day at $164.52, moving 2.59% from the previous trading session.…

AstraZenecas Oncology Engine Keeps Running Despite Wainua Setback

…

AstraZeneca to pay up to $1.5bn for global rights to lung cancer pill

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has agreed to pay $600 million upfront to secure worldwide rights to a lung cancer pill developed…

HSBC downgrades AstraZeneca after key trial failure

HSBC has downgraded AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) to hold from buy, arguing that a recent trial failure has removed the central…

UBS stays positive on AstraZeneca ahead of second-quarter results

UBS expects AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) to report solid second-quarter results later this month, though it sees little room for the…

UBS stuft ASTRAZENECA auf Buy

ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Astrazeneca mit einem Kursziel von 17600 Pence auf…

DEUTSCHE BANK RESEARCH stuft ASTRAZENECA auf Sell

FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Astrazeneca mit einem Kursziel von 11500 Pence auf "Sell"…

AstraZeneca erases billions after sobering reveal

Drug trials fail all the time. What is rare is a failure that costs a company tens of billions of…

AstraZenecas trial flop raises a bigger question: Is its pipeline premium becoming more vulnerable?

For years, AstraZeneca has commanded one of the richest valuations among large European pharma companies on the assumption that it…

Astrazeneca (AZN) Stock Dips While Market Gains: Key Facts

The latest trading day saw Astrazeneca (AZN) settling at $171.61, representing a -3.85% change from its previous close.…

AstraZeneca And Ionis Pharma Rocked By Heart Disease Fail: Why You Shouldnt Panic

…

AstraZenecas Wainua failure hurts credibility more than valuation, Jefferies warns

The damage to AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) from Wainuas trial failure is less about the numbers than about a dent…